Skip to main content
. 2020 Nov 19;5(6):e001035. doi: 10.1136/esmoopen-2020-001035

Figure 3.

Figure 3

Prognostic impact of abnormal neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and presence of both abnormal NLR and PLR in all-cause and cancer-specific mortality.